Taxane-Induced Peripheral Neurotoxicity.

about

Toxicities of Therapeutic Agents Used in Medicine.Serum micronutrients and prealbumin during development and recovery of chemotherapy-induced peripheral neuropathy.Nanoporous 3D-Printed Scaffolds for Local Doxorubicin Delivery in Bone Metastases Secondary to Prostate Cancer

P2860

Q42361402-E3619BDF-BEC9-42CE-AAA6-EEDC05D01DAC Q50237975-D2EB2524-6730-4DC3-BFC2-3EDD05662ACA Q58725397-B00DAF0F-BD1A-49C0-826D-7809A63E6DC6

P2860

Taxane-Induced Peripheral Neurotoxicity.

Item

http://www.wikidata.org/entity/Q45759415

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Taxane-Induced Peripheral Neurotoxicity.

@en

Taxane-Induced Peripheral Neurotoxicity.

@nl

type

Item

label

Taxane-Induced Peripheral Neurotoxicity.

@en

Taxane-Induced Peripheral Neurotoxicity.

@nl

prefLabel

Taxane-Induced Peripheral Neurotoxicity.

@en

Taxane-Induced Peripheral Neurotoxicity.

@nl

P1476

Taxane-Induced Peripheral Neurotoxicity

@en

P2093

Roser Velasco

http://www.w3.org/2001/XMLSchema#string

P2860

Residual neurotoxicity in ovarian cancer patients in clinical remission after first-line chemotherapy with carboplatin and paclitaxel: the Multicenter Italian Trial in Ovarian cancer (MITO-4) retrospective study.

Paclitaxel: new uses for an old drug.

The paradox of paclitaxel neurotoxicity: Mechanisms and unanswered questions

Docetaxel neuropathy: a distal axonopathy

Mitotoxicity in distal symmetrical sensory peripheral neuropathies

THE DEVELOPMENT AND CLINICAL UTILITY OF THE TAXANE CLASS OF ANTIMICROTUBULE CHEMOTHERAPY AGENTS

Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial

Sequencing of Charcot-Marie-Tooth disease genes in a toxic polyneuropathy.

Overall survival benefit for weekly vs. three-weekly taxanes regimens in advanced breast cancer: A meta-analysis.

Individual patient data meta-analysis of docetaxel administered once every 3 weeks compared with once every week second-line treatment of advanced non-small-cell lung cancer.

P304

152-169

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/TOXICS3020152

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jordi Bruna

P577

2015-04-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

276158613

http://www.w3.org/2001/XMLSchema#string

P698

29056655

http://www.w3.org/2001/XMLSchema#string

P921

neurotoxicity

P932

5634686

http://www.w3.org/2001/XMLSchema#string

Taxane-Induced Peripheral Neurotoxicity.

about

P2860

P2860

Taxane-Induced Peripheral Neurotoxicity.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921

P932